Tomoo Kosuge

Q: What Schools Are Affiliated With Tomoo Kosuge

Tomoo Kosuge is affiliated with the following schools: University of Tokyo, Yokohama City University, Juntendo University, Gunma University

Tomoo Kosuge's AcademicInfluence.com Rankings

Tomoo Kosuge

Philosophy

#8731

World Rank

#12166

Historical Rank

Logic

#5754

World Rank

#7179

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Tomoo Kosuge's Degrees

Doctorate Medicine University of Tokyo
PhD Medicine University of Tokyo

Why Is Tomoo Kosuge Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Tomoo Kosuge's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. (1990) (1053)
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial (2000) (838)
Genomic spectra of biliary tract cancer (2015) (809)
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators (2012) (777)
Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions (2006) (736)
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. (2000) (679)
Surgery for small liver cancers. (1993) (677)
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer (2013) (633)
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes (2014) (600)
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma (1990) (431)
Early hepatocellular carcinoma as an entity with a high rate of surgical cure (1998) (392)
A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (2009) (384)
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma (2014) (380)
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma (2007) (348)
FOXP3+ Regulatory T Cells Affect the Development and Progression of Hepatocarcinogenesis (2007) (346)
Long-Term Outcome of Extended Hemihepatectomy for Hilar Bile Duct Cancer With No Mortality and High Survival Rate (2003) (338)
Recurrence of hepatocellular carcinoma after surgery (1996) (334)
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. (1999) (326)
Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. (1994) (303)
High-resolution characterization of a hepatocellular carcinoma genome (2011) (274)
Predictive factors for postoperative recurrence of hepatocellular carcinoma. (1994) (261)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05). (2019) (234)
Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. (1993) (225)
Treatment strategy for small hepatocellular carcinoma: Comparison of long‐term results after percutaneous ethanol injection therapy and surgical resection (2001) (221)
One Hundred Two Consecutive Hepatobiliary Resections for Perihilar Cholangiocarcinoma With Zero Mortality (2006) (212)
Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features (2002) (204)
Factors influencing survival of patients undergoing hepatectomy for colorectal metastases (1999) (202)
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. (2003) (199)
A new staging system for mass‐forming intrahepatic cholangiocarcinoma (2001) (192)
Pathologic Support for Limited Hepatectomy in the Treatment of Liver Metastases from Colorectal Cancer (1995) (190)
Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer (2015) (188)
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection (1996) (180)
Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. (2000) (176)
Pattern of recurrence after hepatic resection for colorectal metastases (1993) (174)
Resection for multiple metastatic liver tumors after portal embolization. (1994) (173)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP-05). (2019) (172)
Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. (2006) (166)
Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer (2007) (159)
Genome‐wide array‐based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome (2007) (156)
Hepatic resection for metastatic tumours from gastric cancer: Analysis of prognostic factors (1994) (154)
Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma (2010) (153)
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery (2012) (152)
Prognostic Significance of Tissue Factor in Pancreatic Ductal Adenocarcinoma (2005) (147)
Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. (1997) (143)
Should hepatomas be treated with hepatic resection or transplantation? (1999) (140)
Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. (2005) (136)
Surgical Outcomes of the Mass-Forming plus Periductal Infiltrating Types of Intrahepatic Cholangiocarcinoma: A Comparative Study with the Typical Mass-Forming Type of Intrahepatic Cholangiocarcinoma (2007) (133)
Possible detection of pancreatic cancer by plasma protein profiling. (2005) (128)
Selection criteria for simultaneous resection in patients with synchronous liver metastasis. (2006) (120)
Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas (2005) (119)
Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma (2014) (118)
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma (2011) (117)
Repeat liver resection for recurrent colorectal liver metastases. (1999) (117)
Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas (2014) (113)
Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic Cancer (2013) (111)
A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer. (2006) (110)
A Preoperative Predictive Scoring System for Postoperative Pancreatic Fistula after Pancreaticoduodenectomy (2011) (109)
Splenectomy in patients with hepatocellular carcinoma and hypersplenism. (2000) (109)
Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. (1992) (107)
Macroscopic intrabiliary growth of liver metastases from colorectal cancer. (1999) (106)
CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. (2010) (104)
Combined hepatocellular carcinoma and cholangiocarcinoma: Clinical features and computed tomographic findings (1993) (103)
Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. (2009) (101)
Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation (2010) (100)
Bloodless liver resection using the Monopolar Floating Ball plus Ligasure diathermy: Preliminary results of 16 liver resections (2004) (99)
The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. (2006) (92)
A new method for mapping hepatic subsegment: counterstaining identification technique. (1991) (91)
PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors (2014) (91)
Minimally Invasive Intraductal Papillary-mucinous Carcinoma of the Pancreas: Clinicopathologic Study of 104 Intraductal Papillary-mucinous Neoplasms (2008) (91)
Prognostic Value of Tumor Architecture, Tumor-Associated Vascular Characteristics, and Expression of Angiogenic Molecules in Pancreatic Endocrine Tumors (2007) (89)
A long‐term follow‐up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy (2005) (88)
Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. (2000) (87)
Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression. (2003) (87)
Expression and Gene Amplification of Actinin-4 in Invasive Ductal Carcinoma of the Pancreas (2008) (86)
Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. (2007) (86)
Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients (1989) (84)
Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis. (1993) (82)
Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. (2007) (81)
Preoperative Evaluation of Invasive and Noninvasive Intraductal Papillary-Mucinous Neoplasms of the Pancreas: Clinical, Radiological, and Pathological Analysis of 123 Cases (2009) (79)
Is celiac axis resection justified for T4 pancreatic body cancer? (2012) (78)
Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. (2005) (78)
Synuclein-γ Is Closely Involved in Perineural Invasion and Distant Metastasis in Mouse Models and Is a Novel Prognostic Factor in Pancreatic Cancer (2009) (77)
Clinical Implications of Combined Portal Vein Resection as a Palliative Procedure in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Head Carcinoma (2006) (76)
Extrahepatic division of the right hepatic vein in hepatectomy. (1991) (76)
Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma (2000) (76)
Small polypoid lesions of the gallbladder: differential diagnosis and surgical indications by helical computed tomography. (1998) (76)
Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer (2011) (75)
An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas (1996) (74)
Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma (2013) (73)
Analysis of Prognostic Factors Affecting Survival After Initial Recurrence and Treatment Efficacy for Recurrence in Patients Undergoing Potentially Curative Hepatectomy for Hepatocellular Carcinoma (2007) (72)
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics (2016) (71)
Hepatic Resection for Metastatic Breast Cancer: Prognostic Analysis of 34 Patients (2005) (70)
New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma--an old problem revisited. (1991) (67)
Ciliated Muconodular Papillary Tumors of the Lung: A Clinicopathologic Analysis of 10 Cases (2015) (67)
Clinical significance of reconstruction of the right hepatic artery for biliary malignancy (2006) (67)
Prognosis of Perihilar Cholangiocarcinoma: Hilar Bile Duct Cancer versus Intrahepatic Cholangiocarcinoma Involving the Hepatic Hilus (2008) (65)
Anterior Transhepatic Approach for Isolated Resection of the Caudate Lobe of the Liver (1999) (65)
Identification of Adipophilin as a Potential Plasma Biomarker for Colorectal Cancer Using Label-Free Quantitative Mass Spectrometry and Protein Microarray (2011) (65)
Efficacy of a Hepatectomy and a Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein (2009) (65)
Invasive Carcinoma Originating in an Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Clinicopathologic Comparison with a Common Type of Invasive Ductal Carcinoma (2006) (65)
Carcinoid tumor arising in a duplication cyst of the duodenum (2006) (65)
The value of ultrasonography for hepatic surgery. (1991) (64)
Repeat hepatic resection for recurrent hepatocellular carcinoma. (1993) (64)
Clinical impact of the surgical margin status in hepatectomy for solitary mass‐forming type intrahepatic cholangiocarcinoma without lymph node metastases (2007) (64)
Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer (2002) (63)
Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas. (2002) (62)
Effectiveness of multimodality treatment for resectable pancreatic Cancer (1990) (60)
Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas. (2005) (60)
Spontaneous Regression of Inflammatory Pseudotumor of the Liver: Report of Three Cases (2007) (60)
Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? (2013) (60)
Genome‐wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma (2009) (59)
Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer (1998) (59)
Analysis of Risk Factors for Delayed Gastric Emptying (DGE) after 387 Pancreaticoduodenectomies with Usage of 70 Stapled Reconstructions (2011) (58)
An isolated, complete resection of the caudate lobe, including the paracaval portion, for hepatocellular carcinoma. (1994) (58)
Second Hepatectomy for Recurrent Colorectal Liver Metastasis: Analysis of Preoperative Prognostic Factors (2006) (58)
Perioperative and long-term outcomes after pancreaticoduodenectomy in elderly patients 80 years of age and older (2013) (58)
Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms (2015) (57)
An isolated caudate lobectomy by the transhepatic approach for hepatocellular carcinoma in cirrhotic liver. (1992) (56)
Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma. A report of four cases. (1994) (55)
New lesions detected by intraoperative ultrasound during liver resection for hepatocellular carcinoma. (2001) (55)
Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray (2011) (55)
Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases (2001) (54)
Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: Analysis of prognostic factors (1992) (54)
Intrapancreatic Nerve Invasion as a Predictor for Recurrence After Pancreaticoduodenectomy in Patients With Invasive Ductal Carcinoma of the Pancreas (2011) (53)
CT of Lymphoepithelial Cysts of the Pancreas (1995) (51)
Increased expression of cyclooxygenase‐2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors (2001) (51)
Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer (2006) (51)
Should the bile duct be preserved or removed in radical surgery for gallbladder cancer? (1999) (50)
Findings in primary hepatic carcinoid tumor: US, CT, MRI, and angiography. (1992) (49)
Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria. (2007) (49)
Prognostic impact of marginal resection for patients with solitary hepatocellular carcinoma: evidence from 570 hepatectomies. (2012) (49)
Personal experience of right anterior segmentectomy (segments V and VIII) for hepatic malignancies. (1993) (49)
Response of early-stage hepatocellular carcinoma and borderline lesions to therapeutic arterial embolization. (1993) (47)
Analysis of 5-Year Survivors After a Macroscopic Curative Pancreatectomy for Invasive Ductal Adenocarcinoma (2010) (47)
Surgical results for hepatocellular carcinoma with bile duct invasion: A clinicopathologic comparison between macroscopic and microscopic tumor thrombus (2005) (47)
Reduced Plasma Level of CXC Chemokine Ligand 7 in Patients with Pancreatic Cancer (2010) (46)
Evaluation of the Therapeutic Effect of Transcatheter Arterial Embolization for Hepatocellular Carcinoma (2000) (46)
Hepatic resection with and without surgical margins for hepatocellular carcinoma in patients with impaired liver function. (1999) (46)
Distribution and therapeutic effect of intraarterially transferred tumor‐infiltrating lymphocytes in hepatic malignancies. A preliminary report (1991) (46)
Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy. (2008) (45)
An analysis of risk factors for pancreatic fistula after pancreaticoduodenectomy: clinical impact of bile juice infection on day 1 (2010) (45)
Basing Treatment Strategy for Non-functional Pancreatic Neuroendocrine Tumors on Tumor Size (2014) (44)
Clinical significance of tumor‐infiltrating immune cells focusing on BTLA and Cbl‐b in patients with gallbladder cancer (2015) (44)
Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics. (2009) (44)
Helical computed tomography in the diagnosis of portal vein invasion by pancreatic head carcinoma: usefulness for selecting surgical procedures and predicting the outcome. (1998) (44)
Proteomic profiling reveals the prognostic value of adenomatous polyposis coli–end‐binding protein 1 in hepatocellular carcinoma (2008) (43)
Solid–pseudopapillary neoplasms of the pancreas in men and women: do they differ? (2006) (43)
A solid pseudopapillary tumor arising from the greater omentum followed by multiple metastases with increasing malignant potential (2006) (42)
Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy. (2001) (41)
Prognosis of patients undergoing hepatectomy for solitary hepatocellular carcinoma originating in the caudate lobe. (2011) (41)
Arterial Reconstruction during Pancreatoduodenectomy in Patients with Celiac Axis Stenosis—Utility of Doppler Ultrasonography (2005) (41)
Altered Plasma Apolipoprotein Modifications in Patients with Pancreatic Cancer: Protein Characterization and Multi-Institutional Validation (2012) (41)
Wrapping the stump of the gastroduodenal artery using the falciform ligament during pancreaticoduodenectomy. (2007) (40)
Epidermoid cyst in an intrapancreatic accessory spleen: CT and pathologic findings. (1998) (40)
Benign tumors of the liver resected because of a diagnosis of malignancy. (1992) (40)
Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time. (1993) (40)
Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics. (2017) (39)
CT evaluation of small polypoid lesions of the gallbladder. (1995) (39)
Influence of preoperative anti‐cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (2014) (39)
Abdominal Pain in Patients with Resectable Pancreatic Cancer with Reference to Clinicopathologic Findings (2001) (39)
Reconstruction of hepatic or portal veins by use of newly customized great saphenous vein grafts (2004) (39)
Resection of peritoneal metastases from hepatocellular carcinoma. (1999) (38)
Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan. (2007) (37)
Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage (2011) (37)
Primary hepatic carcinoid tumors confirmed with long-term follow-up after resection. (1999) (36)
The effect of neoadjuvant chemotherapy with gemcitabine and S-1 for resectable pancreatic cancer (randomized phase II/III trial; Prep-02/JSAP-05). (2019) (36)
Spontaneous regression of hepatocellular carcinoma with complete necrosis: case report (2005) (36)
Nonfunctioning islet cell tumors of the pancreas: clinical, imaging and pathological aspects in 16 patients. (1998) (36)
Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally? (2009) (36)
Reconstruction of the middle hepatic vein tributary during right anterior segmentectomy. (1995) (35)
CT imaging of intrabiliary growth of colorectal liver metastases: a comparison of pathological findings of resected specimens. (2002) (35)
Pancreatic Ducts as an Important Route of Tumor Extension for Acinar Cell Carcinoma of the Pancreas (2010) (34)
Intraductal tubular carcinoma in an adenoma of the main pancreatic duct of the pancreas head (2006) (33)
Reappraisal of the Clinical Significance of Tumor Size in Patients With Pancreatic Ductal Carcinoma (2006) (33)
Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum (2011) (33)
Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. (2007) (32)
A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status (2016) (32)
Clinicopathological and prognostic significance of EGFR , VEGF , and HER 2 expression in cholangiocarcinoma (2010) (32)
Late contrast-enhanced CT for small pancreatic carcinoma: delayed enhanced area on CT with histopathological correlation. (1996) (32)
Surgical Management of Infrahilar/Suprapancreatic Cholangiocarcinoma: an Analysis of the Surgical Procedures, Surgical Margins, and Survivals of 77 Patients (2010) (31)
A hepatoblastoma originating in the caudate lobe radically resected with the inferior vena cava. (1991) (30)
Cystic liver metastases from colorectal cancer (2000) (30)
Safety and Effectiveness of Left Hepatic Trisegmentectomy for Hilar Cholangiocarcinoma (2005) (29)
Randomized clinical trial of hepatectomy using intermittent pedicle occlusion with ischaemic intervals of 15 versus 30 minutes (2006) (28)
Left hepatic trisectionectomy for advanced perihilar cholangiocarcinoma (2013) (28)
Re‐reconstruction of a single remnant hepatic vein (1996) (28)
Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter (2008) (28)
Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients. (2016) (27)
Long-term survival after multimodality treatment for resectable pancreatic cancer (2000) (27)
Optimal Indications for Additional Resection of the Invasive Cancer-Positive Proximal Bile Duct Margin in Cases of Advanced Perihilar Cholangiocarcinoma (2015) (26)
Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth (2009) (26)
Role of Medial Pancreatectomy in the Management of Intraductal Papillary Mucinous Neoplasms and Islet Cell Tumors of the Pancreatic Neck and Body (2008) (26)
Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass (2012) (26)
His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk. (2008) (26)
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment (2010) (25)
Liver cryptococcosis manifesting as obstructive jaundice in a young immunocompetent man: Report of a case (2008) (25)
Hepatectomy for metastatic renal cell carcinoma. (1997) (25)
Choice of treatments for small hepatocellular carcinoma: Hepatectomy, embolization or ethanol injection (1991) (25)
Systemic Chemotherapy for Pancreatic Cancer (2004) (24)
Long-term recurrence-free survival in a patient with primary hepatic carcinosarcoma: case report with a literature review. (2010) (24)
Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial (2017) (23)
Analysis of biliary drainage in the caudate lobe of the liver: comparison of three-dimensional CT cholangiography and rotating cine cholangiography. (1997) (23)
Computed tomography of pancreatic adenocarcinoma: comparison of tumor size measured by dynamic computed tomography and histopathologic examination. (1996) (22)
The type of preoperative biliary drainage predicts short-term outcome after major hepatectomy (2016) (22)
Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery (2007) (22)
Successful outcome after resection of pancreatic cancer with a solitary hepatic metastasis. (2004) (22)
Is Preservation of the Remnant Stomach Safe During Distal Pancreatectomy in Patients Who Have Undergone Distal Gastrectomy? (2013) (21)
Reconstruction of the portal and hepatic veins using venous grafts customized from the bilateral gonadal veins (2009) (21)
Genetic inactivation of the APC gene contributes to the malignant progression of sporadic hepatocellular carcinoma: A case report (2006) (21)
Accuracy of computed tomography in determining pancreatic cancer tumor size. (1994) (20)
Preoperative identification of intraoperative blood loss of more than 1,500 mL during elective hepatectomy (2011) (20)
Simple segmental resection of the second portion of the duodenum for the treatment of gastrointestinal stromal tumors (2008) (20)
Serous cystadenoma of the pancreas communicating with a pancreatic duct (1996) (20)
Intrahepatic cholangiocarcinoma presenting intrabile duct extension: clinicopathologic study of five resected cases. (1997) (20)
Definition of T3/4 and Regional Lymph Nodes in Gallbladder Cancer: Which Is More Valid, the UICC or the Japanese Staging System? (2012) (20)
Signet-ring cell carcinoid: a primary hepatic carcinoid tumor with cytoplasmic inclusions comprising of aggregates of keratin. (1992) (19)
Clear Cell Endocrine Tumor of the Pancreas Which is Not Associated with von Hippel-Lindau Disease: Report of a Case (2003) (19)
Pancreas-sparing duodenectomy for gastrointestinal stromal tumor. (2014) (19)
Preoperative portal embolization. (1997) (19)
Effect of Heavy Alcohol Intake on Long‐term Results after Curative Resection of Hepatitis C Virus‐related Hepatocellular Carcinoma (1996) (19)
Thoracoabdominal approaches versus inverted T incision for posterior segmentectomy in hepatocellular carcinoma. (2000) (19)
The prognosis of patients with hepatocellular carcinoma of multicentric origin. (1996) (18)
Comparison between thoracoabdominal and abdominal approaches in occurrence of pleural effusion after liver cancer surgery. (1997) (18)
Retroperitoneal schwannoma mimicking hepatic tumor in the caudate lobe. (1997) (18)
A novel splicing mutation (894-9 G --> A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1. (1999) (18)
Solitary hepatic lymphangioma: Report of a case (2010) (18)
Hepatic artery reconstruction following ablative surgery for hepatobiliary and pancreatic malignancies. (2012) (18)
Resection of liver metastases after pancreatoduodenectomy: report of seven cases. (1999) (18)
Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma. (2014) (18)
Surgery of icteric-type hepatoma after biliary drainage and transcatheter arterial embolization. (1999) (18)
Adjuvant treatments for resectable pancreatic cancer. (2008) (17)
Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization. (1996) (17)
Ductal adenocarcinoma of the pancreas associated with intratumoral calcification (1995) (17)
Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma (2009) (17)
Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma. (2014) (17)
Administration of Pancrelipase as Effective Treatment for Hepatic Steatosis After Pancreatectomy (2015) (17)
Primary lymphoma of the common bile duct. (1991) (16)
Successful Resection of Hepatocellular Carcinoma with Bronchobiliary Fistula Caused by Repeated Transcatheter Arterial Embolizations: Report of a Case (2007) (16)
[Intrahepatic cholangiocarcinoma: proposal of new macroscopic classification]. (1993) (16)
Mortality, morbidity, and failure to rescue in hepatopancreatoduodenectomy: An analysis of patients registered in the National Clinical Database in Japan (2021) (16)
Hepatobiliary resection with inferior vena cava resection and reconstruction using an autologous patch graft for intrahepatic cholangiocarcinoma (2008) (15)
Is surgical resection justified for stage IV colorectal cancer patients having bilobar hepatic metastases?—an analysis of survival of 77 patients undergoing hepatectomy (2010) (15)
Adenosquamous carcinoma with different morphologic and histologic components arising from the intrahepatic bile duct: report of a case. (1996) (15)
Intrapancreatic accessory spleen (1994) (15)
Liver abscess after percutaneous ethanol injection (PEI) therapy for hepatocellular carcinoma. A case report. (1993) (15)
Roux-en-Y reconstruction using staplers during pancreaticoduodenectomy: Results of a prospective preliminary study (2009) (14)
Helical CT of the abdomen after pancreaticoduodenectomy: usefulness for detecting postoperative complications. (1997) (14)
Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma. (2012) (14)
Nonoperative removal of bilateral intrahepatic biliary stones by endoscopic electrohydraulic lithotripsy. (1990) (13)
Pseudoaneurysm of the Cystic Artery Associated with Xanthogranulomatous Cholecystitis (2008) (13)
Pancreaticojejunostomy with invagination of the punched pancreatic remnant after medial pancreatectomy and enucleation for multiple metastases of renal cell carcinoma: Report of a case (2009) (13)
[Surgical strategy for hepatocellular carcinoma of the caudate lobe]. (1991) (12)
Invasive biliary cystic tumor without ovarian‐like stroma (2007) (12)
Histological prognostic parameters for adenocarcinoma of the pancreatic head. Proposal for a scoring system for prediction of outcome (1997) (12)
Mucinous micropapillary pattern in lung adenocarcinomas: a unique histology with genetic correlates (2016) (12)
Extended Left Hepatectomy by Severing All Major Hepatic Veins with Reconstruction of the Right Hepatic Vein (2004) (12)
Surgical management of biliary cystadenocarcinoma. (1992) (11)
Morphology and Pathological Significance of Focal Acinar Cell Dysplasia of the Human Pancreas (1992) (11)
Assessment of the Interface Between Retroperitoneal Fat Infiltration of Pancreatic Ductal Carcinoma and the Major Artery by Multidetector-Row Computed Tomography: Surgical Outcomes and Correlation with Histopathological Extension (2012) (11)
Thickening at the root of the superior mesenteric artery on sonography: evidence of vascular involvement in patients with cancer of the pancreas. (1991) (11)
Risk factors for early bilirubinemia after major hepatectomy for perihilar cholangiocarcinoma with portal vein embolization. (2010) (11)
Delayed Gastric Emptying After Stapled Versus Hand-Sewn Anastomosis of Duodenojejunostomy in Pylorus-Preserving Pancreaticoduodenectomy: a Randomized Controlled trial (2016) (11)
Computed tomography of sclerosing hepatocellular carcinoma. (1992) (10)
Intraductal papillary components in invasive ductal carcinoma of the pancreas are associated with long-term survival of patients. (2001) (10)
Blood supply to the pancreatic head, bile duct, and duodenum: evaluation by computed tomography during arteriography. (1999) (9)
Mucin-Producing Carcinoma of the Gallbladder: Evaluation by Magnetic Resonance Cholangiopancreatography in Three Cases (2012) (9)
Hilar cholangiocarcinoma evaluated by three-dimensional CT cholangiography and rotating cine cholangiography. (2000) (9)
Repeated radical resection and intraoperative irradiation for recurrent pancreatic ductal adenocarcinoma after pancreatoduodenectomy. (1995) (9)
Antitumor effect induced by dendritic cell (DC)-based immunotherapy against peritoneal dissemination of the hamster pancreatic cancer. (2004) (9)
A new alternative hepatectomy method for resection of segments 3 and 4 of the liver. (1992) (8)
Diagnosis and Prognostication of Ductal Adenocarcinomas of the Pancreas Based on Genome-Wide DNA Methylation Profiling by Bacterial Artificial Chromosome Array-Based Methylated CpG Island Amplification (2010) (8)
Growing cavernous haemangioma of the liver: 11‐fold increase in volume in a decade (1991) (8)
Minute pancreatic adenocarcinoma presenting with stenosis of the main pancreatic duct (2002) (7)
Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma (2016) (7)
Pancreatic Intraglandular Metastasis Predicts Poorer Outcome in Postoperative Patients With Pancreatic Ductal Carcinoma (2013) (7)
Serum bile acid profile in thyroid dysfunction and effect of medical treatment. (1987) (7)
Adenocarcinoma Confined to a Cholesterol Polyp of the Gallbladder (1999) (7)
Gemcitabine in Patients With Intraductal Papillary Mucinous Neoplasm With an Associated Invasive Carcinoma of the Pancreas (2013) (7)
Optimal cut‐off value for the number of colorectal liver metastases: a project study for hepatic surgery of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (2014) (7)
Safe management of the pancreatic remnant with prolamine duct occlusion after extended pancreaticoduodenectomy. (2005) (7)
Clinicopathological features of recurrent primary liver cancer in Japan (1992) (7)
[Refractory immune thrombocytopenic purpura accompanied with avascular necrosis of femoral head receiving the combination of high dose immunoglobulin therapy followed by platelet transfusion could successfully be managed to undergo surgery]. (1994) (6)
[Preoperative portal embolization increases safety of hepatectomy]. (1991) (6)
Adenocarcinoma and concomitant intraductal papillary adenoma in the pancreas. (1991) (6)
Early venous return in hepatic angiomyolipoma due to an intratumoral structure resembling an arteriovenous fistula (2014) (6)
Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case. (1996) (6)
New Portal-Superior Mesenteric Vein Reconstructions Using First Jejunal Vein Flap in Pancreaticoduodenectomy (2016) (6)
CT diagnosis of intraductal papillary neoplasm of the pancreas in comparison with histopathologic findings (1996) (6)
Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapy. (2012) (6)
Extended right hemihepatectomy as a salvage operation for recurrent bile duct cancer 3 years after pancreatoduodenectomy. (2006) (6)
Outcomes of pancreaticoduodenectomy in patients with chronic hepatic dysfunction including liver cirrhosis: results of a retrospective multicenter study by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (2019) (6)
Hepatic resection of metastases from colorectal cancers. (1991) (5)
Influence of alcohol abuse on recurrence after curative resection of hepatocellular carcinoma. (1995) (5)
Evidence of effective multidisciplinary treatment for resectable pancreatic cancer from the viewpoint of the CA19-9 level (1991) (5)
Postoperative adjuvant therapy (2011) (5)
Intraductal dissemination of papillary adenocarcinoma of the ampulla of Vater in the pancreatic duct (2014) (5)
Prolyl 4-Hydroxylation of α-Fibrinogen (2009) (5)
Systematic subsegmentectomy for hepatocellular carcinoma (1992) (5)
Curative resection of hepatocellular carcinoma with intrabile duct tumor growth mimicking hilar bile duct carcinoma (1995) (4)
Invasive ductal carcinoma developing in pancreas with severe Fatty infiltration. (2012) (4)
[Systematic resection for hepatocellular carcinoma]. (1998) (4)
[Effectiveness of intraoperative cytological examination of peritoneal washings for patients with pancreatic cancer]. (1992) (4)
Pheochromocytoma growing exophytically from the right adrenal gland and invaginating into the liver. (1997) (4)
A case of endocrine cell carcinoma of the gallbladder. (2003) (4)
Total pancreatectomy with en bloc celiac axis resection for a pancreatic adenocarcinoma involving both the gastroduodenal artery and the celiac artery. (2011) (4)
[Segmentectomy under echographic control on cirrhotic liver]. (1991) (3)
Complete drainage of pancreatic juice from the cut edge of the pancreas after subtotal left-side pancreatectomy. (2000) (3)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus surgery-first for resectable pancreatic carcer (Prep-02/JSAP05). (2015) (3)
Erythropoietin production caused by metastatic colon cancer (2010) (3)
Reconstruction of hepatic venous tributaries using a Y-shaped left portal vein graft harvested from a resected left liver. (2008) (3)
Selective intraarterial contrast-enhanced CT of pancreaticoduodenal tumors: early clinical experience in evaluating blood supply and detectability. (2000) (3)
M1533 Hepatobiliary Resection with Inferior Vena Cava Resection and Reconstruction Using An Autologous Patch Graft for Intrahepatic Cholangiocarcinoma (2008) (3)
Prognostic significance of flow cytometric DNA analysis in hepatocellular carcinoma: a prospective study of 124 patients (1993) (3)
3504 ORAL A randomized phase III study comparing gemcitabine monotherapy with observation in patients with resected pancreatic cancer (2007) (3)
[Hepatocellular carcinoma originated in the caudate lobe]. (1995) (3)
[A case of acute eosinophilo-myelomonocytic leukemia with peripheral basophilia]. (1988) (3)
Carcinoma of the cystic bile duct: MRCP and CT appearance. (1999) (2)
Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial (2017) (2)
[Long-term results after hepatectomy for hepatocellular carcinoma according to cancer stage]. (1998) (2)
Report of the 16th International Symposium of the Foundation for Promotion of Cancer Research: Recent advances in pancreatic cancer. (2003) (2)
Successful radical surgery for an undifferentiated gallbladder carcinoma with lymph node metastases to the mesocolon. (1996) (2)
Accelerated tumor growth and changes in images concomitant with vascularization in a patient with hepatocellular carcinoma. (1991) (2)
A phase II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP-03). (2012) (2)
Histopathological characteristics of hypervascular cholangiocellular carcinoma as an early stage of cholangiocellular carcinoma (2014) (2)
[Control of aftereffects due to intraoperative radiotherapy]. (1990) (2)
A Case of Pancreatic Abscess Mimicking Mucinous Cystic Tumor of the Pancreas (2004) (2)
Function-preserving segmentectomy of the cirrhotic liver. (1995) (2)
A conundrum for randomized controlled trials: experience from a small hepatocellular carcinoma trial. (2010) (2)
Spontaneous Regression of Infl ammatory Pseudotumor of the Liver: Report of Three Cases (2007) (2)
[Surgical treatment of small hepatocellular carcinoma]. (1996) (1)
[Surgical treatment of liver metastases from colorectal cancer patient selection and oncological outcome]. (2001) (1)
Bile acid profile and decrement rate of serum total bilirubin after biliary drainage (1990) (1)
Conventional and Pylorus Preserving Pancreatoduodenectomy for Invasive Ductal Pancreatic Cancer. (1999) (1)
New digestion chamber for the automated isolation method of pancreatic islets. (1994) (1)
Slow growth of small pancreatic carcinoma with a 20-04 follow-up. (2009) (1)
[Clinical trial of alpha-interferon (human lymphoblastoid interferon) in combination with VCAP chemotherapy in multiple myeloma]. (1991) (1)
Results of the surgery in carcinoma of the gall bladder. (1986) (1)
[Idiopathic myelofibrosis transformed to acute myelomonocytic leukemia associated with non-Hodgkin's lymphoma]. (1994) (1)
Prognostic Significance ofTissue Factor in Pancreatic Ductal Adenocarcinoma (2005) (1)
[Result of surgical resection of hepatocellular carcinoma in possible candidates for nonsurgical treatments]. (1992) (1)
[Selection of methods for diagnosis and treatment of pancreatic cancer]. (1992) (1)
Imaging features of large intraductal papillary mucinous carcinoma of the pancreatic tail. (2006) (1)
[Metastatic liver tumor]. (1995) (1)
Resection of liver granulomas under a diagnosis of metastases from breast cancer (2000) (1)
Contents Vol. 58, 2000 (2000) (0)
Stapled vs hand-sewn anastomosis of duodenojejunostomy in pylorus-preserving pancreaticoduodenectomy: a randomized controlled trial (2014) (0)
Improved Results after Resection of Pancreatic Cancer. (1997) (0)
[The changes in bile acid profile in serum after the release of extrahepatic biliary obstruction]. (1987) (0)
A case of pathological complete response after combination chemotherapy by sorafenib and cisplatin hepatic arterial infusion for an advanced hepatocellular carcinoma (2013) (0)
New intraoperative biliary manometric technique using a balloon catheter--selective evaluation of papillary function. (1989) (0)
Reappraisal of lymph node dissection along the 1st jejunal artery for pancreaticoduidenectomy (2016) (0)
A Case of Gastrinoma Presented Marked Skip Metastasis to the Para-Aortic Lymph Nodes (2007) (0)
M1616 Role of Extended Right Hemihepatectomy for Gallbladder Carcinoma Involving the Hepatic Hilus (2010) (0)
Su1774 Evaluation of Completion Rate of ‘Upfront Surgery and Adjuvant Chemotherapy’ According to Resectable Status of Pancreatic Head Cancers (2015) (0)
Mo1611 Hepatectomy for Non-Colorectal or Non-Neuroendocrine Liver Metastases (2014) (0)
Mo1661 Does the Pancreatic Resection Have Any Survival Benefit in Patients With a Pancreatic Adenocarcinoma and Intraoperatively Diagnosed Positive Para-Aortic Lymph Node Metastasis or Peritoneal Lavage Cytology? (2015) (0)
Evaluation of papillary function using a new catheter with a balloon-influences of volume and compliance of biliary system on choledochal pressure measurement. (1988) (0)
ISY2-2Adjuvant and neoadjuvant therapy for resectable pancreatic cancer (2015) (0)
Mo1455 Extended Left Hepatic Trisectionectomy as a Feasible Surgical Procedure for Advanced Perihilar Cholangiocarcinoma (2012) (0)
Mo1692 Extended Hepatectomy With Portal and Hepatic Artery Resection for Advanced Perihilar Cholangiocarcinoma (2013) (0)
Abstract 1055: Genome-wide DNA methylation analysis in precancerous conditions associated with hepatitis B virus and hepatitis C virus infection (2015) (0)
[Surgical treatment of pancreatic cancer]. (2006) (0)
NOVEL PROTEIN MODIFICATION-Fibrinogen : A α Prolyl 4-Hydroxylation of Modification , and Degradation : Protein Synthesis , Post-Translational (2009) (0)
5th Japanese Association of Hepato‐Biliary‐Pancreatic Surgery (1993) (0)
Subject Index Vol. 58, 2000 (2000) (0)
409 Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies against apolipoprotein-AII isoforms (2015) (0)
[Evidences for adjuvant therapy of resected pancreatic cancer]. (2011) (0)
SY11-2ADJUVANT CHEMOTHERAPY FOR RESECTED PANCREATIC CANCER: FOCUSING ON THE JSAP STUDY (2014) (0)
Pre-operative transcatheter arterial embolization (TAE) and TAE for recurrences: A role of TAE from the view point of hepatectomy (1991) (0)
Two Patients with Growing Cavernous Hemangioma of the Liver. Quantitative Documentation of the Growth. (1991) (0)
Abstracts of selected papers presented at the 33rd annual meeting of the japanese society of gastroenterology (2007) (0)
Recent technical advancements in segmentectomy subsegmentectomy, and limited resection in patients with small hepatocellular carcinoma and liver cirrhosis with special reference to intraoperative ultrasonography (1991) (0)
Mo1735 Analysis of Clinicopathological Factors Contributing an Actual 5 Year Survival After Hepatectomy for Intrahepatic Cholangiocarcinoma (2013) (0)
Determination of Surgical Procedures by Preoperative Diagnosis. Hepatocellular Carcinoma. (1992) (0)
Su1545 Reconsideration of Safety and Efficacy of Pancreaticoduodenectomy for Periampullary Cancers in Elderly Patients Aged ≥ 80 Years (2012) (0)
Hepatocellular Carcinoma Associated with Diabetes and Hyperaldosteronemia in a Young Adult Patient (2007) (0)
Localized nodular idiopathic retroperitoneal fibrosis: successful treatment with surgical resection. (1999) (0)
Prognosis of surgical patients with hepatocellular carcinoma, with reference to flow cytometric DNA analysis from fresh materials (1991) (0)
T1695 Comparison Hilar Bile Duct Cancer with Intrahepatic Cholangiocarcinoma Involving the Hepatic Hilus (2008) (0)
A phase I and pharmacokinetic clinical trial of oral administration of the acyclic retinoid NIK-333 (2005) (0)
A phase I/II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP-03). (2012) (0)
Assessment of Peripancreatic Fat Infiltration of Pancreatic Ductal Adenocarcinoma by Multidetector-Row Computed Tomography: Correlation to Extrapancreatic Nerve Invasion and Surgical Outcomes (2011) (0)
[Statistical review of primary liver cancer]. (1993) (0)
M1548 Efficacy of Hepatectomy and Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein (2009) (0)
Dysadherin O verexpression i n P ancreatic D uctal Adenocarcinoma R eflects T umor A ggressiveness: R elationship to E -Cadherin E xpression (2003) (0)
Surgical treatment of hepatocellular carcinoma. (1995) (0)
Tu1615 Prognostic Value of Additional Pancreatic Resection for Cancer Positive Cut Margins During Pancreaticoduodenectomy for Pancreatic Head Cancer (2014) (0)
Plasma biomarker for detecting early stage and risk disease of pancreatic cancer by Apolipoprotein-A2 isoforms (2016) (0)
Japan-Korea Cooperative Project : Pancreatic Surgery Proposed from Japan The Impact of Pancreatic Duct Stent in Pancreatic Fistula Following Pancreaticoduodenectomy (2014) (0)
Indication for local ablation therapy for small HCC with reference to intrahepatic metastasis (2001) (0)
Systematic sub segmentectomy for hepatocellular carcinoma (1992) (0)
The clinical significance of juxtapapillary duodenal diverticula in patients with cholelithiasis. (1988) (0)
Abstract 4580: Detection of early-stage pancreatic cancer by mass spectrometry: a multi-institutional validation study (2010) (0)
T1592 Clinicopathologic Features of Actual 5-Year Survivors After Macroscopic Curative Resection for Invasive Ductal Carcinoma of the Pancreas (2009) (0)
Abstracts of selected papers presented at the 78th general meeting of the Japanese Society of Gastroenterology (1993) (0)
A Case of Hepatic Arterial Resection Combined with Pancreaticoduodenectomy with Juvenile Ductal Carcinoma of the Pancreas (2007) (0)
Pancreatic neuroendocrine tumors: Twenty years' experience of 100 patients at a single center. (2012) (0)
[Surgical treatment of liver cancer--advances in operative procedure and its outcome]. (1991) (0)
W1667 Preoperative Predictors of Increased Intraoperative Blood Loss During Hepatectomy (2010) (0)
[Intraoperative ultrasound for the diagnosis of hepatocellular carcinoma]. (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Tomoo Kosuge?

Tomoo Kosuge is affiliated with the following schools: